158 related articles for article (PubMed ID: 22719809)
1. Use of methylene blue in the treatment of refractory vasodilatory shock after cardiac assist device implantation: report of four consecutive cases.
Michel S; Weis F; Sodian R; Beiras-Fernandez A; Bigdeli AK; Kaczmarek I; Bruegger D
J Clin Med Res; 2012 Jun; 4(3):212-5. PubMed ID: 22719809
[TBL] [Abstract][Full Text] [Related]
2. [Methylene blue in the treatment of vasodilatory shock: a Meta-analysis].
Zhang X; Gao Y; Pan P; Wang Y; Li W; Yu X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Nov; 29(11):982-987. PubMed ID: 29151412
[TBL] [Abstract][Full Text] [Related]
3. Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass?
Leyh RG; Kofidis T; Strüber M; Fischer S; Knobloch K; Wachsmann B; Hagl C; Simon AR; Haverich A
J Thorac Cardiovasc Surg; 2003 Jun; 125(6):1426-31. PubMed ID: 12830064
[TBL] [Abstract][Full Text] [Related]
4. Use of Intravenous Hydroxocobalamin without Methylene Blue for Refractory Vasoplegic Syndrome After Cardiopulmonary Bypass.
Peyko V; Finamore M
Am J Case Rep; 2021 Jun; 22():e930890. PubMed ID: 34143764
[TBL] [Abstract][Full Text] [Related]
5. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent.
Argenziano M; Chen JM; Choudhri AF; Cullinane S; Garfein E; Weinberg AD; Smith CR; Rose EA; Landry DW; Oz MC
J Thorac Cardiovasc Surg; 1998 Dec; 116(6):973-80. PubMed ID: 9832689
[TBL] [Abstract][Full Text] [Related]
6. Vasopressin and methylene blue: alternate therapies in vasodilatory shock.
Lavigne D
Semin Cardiothorac Vasc Anesth; 2010 Sep; 14(3):186-9. PubMed ID: 20705641
[TBL] [Abstract][Full Text] [Related]
7. Improvement in Hemodynamics After Methylene Blue Administration in Drug-Induced Vasodilatory Shock: A Case Report.
Laes JR; Williams DM; Cole JB
J Med Toxicol; 2015 Dec; 11(4):460-3. PubMed ID: 26310944
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic Agents for the Treatment of Vasodilatory Shock.
Knotzer H; Poidinger B; Kleinsasser A
Curr Pharm Des; 2019; 25(19):2133-2139. PubMed ID: 31272348
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of methylene blue in an experimental model of calcium channel blocker-induced shock.
Jang DH; Donovan S; Nelson LS; Bania TC; Hoffman RS; Chu J
Ann Emerg Med; 2015 Apr; 65(4):410-5. PubMed ID: 25441767
[TBL] [Abstract][Full Text] [Related]
10. A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement.
Argenziano M; Choudhri AF; Oz MC; Rose EA; Smith CR; Landry DW
Circulation; 1997 Nov; 96(9 Suppl):II-286-90. PubMed ID: 9386112
[TBL] [Abstract][Full Text] [Related]
11. Local cutaneous necrosis secondary to a prolonged peripheral infusion of methylene blue in vasodilatory shock.
Dumbarton TC; Gorman SK; Minor S; Loubani O; White F; Green R
Ann Pharmacother; 2012 Mar; 46(3):e6. PubMed ID: 22388329
[TBL] [Abstract][Full Text] [Related]
12. A Reminder of Methylene Blue's Effectiveness in Treating Vasoplegic Syndrome after On-Pump Cardiac Surgery.
Manghelli J; Brown L; Tadros HB; Munfakh NA
Tex Heart Inst J; 2015 Oct; 42(5):491-4. PubMed ID: 26504450
[TBL] [Abstract][Full Text] [Related]
13. Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock.
Morales DL; Gregg D; Helman DN; Williams MR; Naka Y; Landry DW; Oz MC
Ann Thorac Surg; 2000 Jan; 69(1):102-6. PubMed ID: 10654495
[TBL] [Abstract][Full Text] [Related]
14. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report.
Workum JD; Keyany A; Jaspers TCC
Toxicol Rep; 2023 Dec; 11():141-144. PubMed ID: 37520772
[TBL] [Abstract][Full Text] [Related]
15. Methylene blue administration in septic shock: a clinical trial.
Preiser JC; Lejeune P; Roman A; Carlier E; De Backer D; Leeman M; Kahn RJ; Vincent JL
Crit Care Med; 1995 Feb; 23(2):259-64. PubMed ID: 7532559
[TBL] [Abstract][Full Text] [Related]
16. Methylene blue for vasodilatory shock in the intensive care unit: a retrospective, observational study.
Naoum EE; Dalia AA; Roberts RJ; Devine LT; Ortoleva J
BMC Anesthesiol; 2022 Jun; 22(1):199. PubMed ID: 35761204
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of methylene blue in patients with vasodilatory shock: A systematic review and meta-analysis.
Zhao CC; Zhai YJ; Hu ZJ; Huo Y; Li ZQ; Zhu GJ
Front Med (Lausanne); 2022; 9():950596. PubMed ID: 36237547
[TBL] [Abstract][Full Text] [Related]
18. Severe Undifferentiated Vasoplegic Shock Refractory to Vasoactive Agents Treated with Methylene Blue.
Manji F; Wierstra B; Posadas J
Case Rep Crit Care; 2017; 2017():8747326. PubMed ID: 29098094
[TBL] [Abstract][Full Text] [Related]
19. Methylene Blue for Vasoplegic Syndrome.
Booth AT; Melmer PD; Tribble B; Mehaffey JH; Tribble C
Heart Surg Forum; 2017 Oct; 20(5):E234-E238. PubMed ID: 29087290
[TBL] [Abstract][Full Text] [Related]
20. Vasopressor therapy in critically ill patients with shock.
Russell JA
Intensive Care Med; 2019 Nov; 45(11):1503-1517. PubMed ID: 31646370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
